Results 321 to 330 of about 481,695 (368)
What's New? Only about one‐fifth of patients with pancreatic ductal adenocarcinoma (PDAC) qualify for curative treatment approaches employing adjuvant chemotherapy. Tools to predict PDAC response to chemotherapeutic regimens, however, are lacking.
Christine Nitschke+15 more
wiley +1 more source
Post COVID Condition and Long-Term COVID-19 Impact on Hepatic Decompensation and Survival in Cirrhosis: A Propensity Matched Observational Study. [PDF]
Sharma P+10 more
europepmc +1 more source
FIGO guideline on liver disease and pregnancy
Abstract The number of women entering pregnancy with chronic liver disease is rising. Gestational liver disorders affect 3% of the pregnant population. Both can be associated with significant maternal and fetal morbidity and mortality. European guidance has recently been published to inform management.
Melanie Nana+24 more
wiley +1 more source
The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021. [PDF]
Tham EKJ+19 more
europepmc +1 more source
Antimicrobial susceptibility analysis of clinical Eggerthella lenta isolates. This study reviewed 36 E. lenta isolates from the bloodstream and abdominal fluids (2018–2024). Identification methods included VITEK 2 ANC, MALDI‐TOF, and 16S rRNA sequencing. Antimicrobial susceptibility testing using agar dilution followed CLSI and EUCAST guidelines.
Yuan Gao+4 more
wiley +1 more source
Burden of illness for patients with primary biliary cholangitis: an observational study of clinical characteristics and healthcare resource utilization. [PDF]
Gish RG+7 more
europepmc +1 more source
Clinical characteristics of patients with chronic hepatitis c infection at initial presentation to tertiary care in an Asian middle-income country [PDF]
Azzeri, Amirah+6 more
core
Our study provides a comprehensive multi‐omics profile of aging, integrating proteomic, metabolomic, and metagenomic analyses across diverse tissues and plasma. We identified the synergistic amplification of the circulating complement system and tissue‐wide immunoglobulin accumulation as key molecular drivers of inflammaging.
Feng Zhang+17 more
wiley +1 more source
Clinical efficacy of transjugular intrahepatic portosystemic shunt in treating esophageal variceal bleeding in patients with liver cirrhosis. [PDF]
Zhao Q, Zi Q, Dong G, Lu Y, Zhang Y.
europepmc +1 more source
Novel biomarker emergence plays a critical role in improving CHB management. Advances in sensitive detection methods, AI, and large‐scale data platforms have independently contributed to biomarkers while driving the development of multi‐omics approaches.
Yaru Shi, Rong Fan
wiley +1 more source